SL Science Holding Limited Ordinary Shares (SLBT) - Total Assets
Based on the latest financial reports, SL Science Holding Limited Ordinary Shares (SLBT) holds total assets worth $2.82 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of SL Science Holding Limited Ordinary Shar to assess how comfortably operating cash covers total debt obligations.
SL Science Holding Limited Ordinary Shares - Total Assets Trend (2023–2025)
This chart illustrates how SL Science Holding Limited Ordinary Shares's total assets have evolved over time, based on quarterly financial data. See SLBT total equity for net asset value and shareholders' equity analysis.
SL Science Holding Limited Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2025)
SL Science Holding Limited Ordinary Shares's total assets of $2.82 Million consist of 50.7% current assets and 49.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 44.7% |
| Accounts Receivable | $129.70K | 4.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how SL Science Holding Limited Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SLBT company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SL Science Holding Limited Ordinary Shares's current assets represent 50.7% of total assets in 2025, a decrease from 82.4% in 2023.
- Cash Position: Cash and equivalents constituted 44.7% of total assets in 2025, up from 6.5% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is accounts receivable at 4.6% of total assets.
SL Science Holding Limited Ordinary Shares Competitors by Total Assets
Key competitors of SL Science Holding Limited Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
USA | $1.53 Billion |
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $8.68 Billion |
|
Bachem Holding AG
SW:BANB
|
Switzerland | CHF2.11 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Beijing Hotgen Biotech Co Ltd
SHG:688068
|
China | CN¥3.21 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥28.15 Billion |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
Germany | €249.51 Million |
|
CorMedix Inc
NASDAQ:CRMD
|
USA | $826.14 Million |
SL Science Holding Limited Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.05 | 84.61 | 84.61 |
| Quick Ratio | 3.05 | 64.96 | 64.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $958.29K | $5.79 Million | $5.79 Million |
SL Science Holding Limited Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between SL Science Holding Limited Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1072.95 |
| Latest Market Cap to Assets Ratio | 941.51 |
| Asset Growth Rate (YoY) | -52.5% |
| Total Assets | $2.82 Million |
| Market Capitalization | $2.65 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values SL Science Holding Limited Ordinary Shares's assets at a significant premium (941.51x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: SL Science Holding Limited Ordinary Shares's assets decreased by 52.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for SL Science Holding Limited Ordinary Shares (2023–2025)
The table below shows the annual total assets of SL Science Holding Limited Ordinary Shares from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.82 Million | -52.51% |
| 2024-12-31 | $5.93 Million | +39.84% |
| 2023-12-31 | $4.24 Million | -- |
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was for… Read more